The inexplicable and relentless rise of cancer-drug prices - The Washington Post
▻https://www.washingtonpost.com/news/wonk/wp/2016/05/02/the-inexplicable-and-relentless-rise-of-cancer-drug-prices
“A lot of times, I’ve heard manufacturers say we can only give the drug to 1,000 patients; we need a high price to recoup costs of research and development. Then all of a sudden, they’re able to sell it to 10,000 patients. You’d think it [the costs] would be distributed across all patients and be cheaper. I think the argument that they’re trying to recoup the research and development over 1,000 patients is not actually representative of what’s going on,” said Caroline Bennette, a health economist at the University of Washington in Seattle who led the Health Affairs study.
